DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00966602 (ClinicalTrials.gov)	September 2009	25/8/2009	Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects	A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects	Cystic Fibrosis	Drug: VX-809;Drug: VX-770;Drug: VX-809 & VX-770;Drug: Placebo	Vertex Pharmaceuticals Incorporated	NULL	Completed	18 Years	55 Years	Both	24	Phase 1	Netherlands

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

September 2009

25/8/2009

Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects

Cystic Fibrosis

Drug: VX-809;Drug: VX-770;Drug: VX-809 & VX-770;Drug: Placebo

Vertex Pharmaceuticals Incorporated

NULL

Completed

18 Years

55 Years

Both

Phase 1

Netherlands